{
    "nctId": "NCT01840306",
    "briefTitle": "Exosomal and Free Extracellular RNAs and Proteins as Predictive Biomarkers for HER2 Therapies in Breast Cancer",
    "officialTitle": "Exosomal and Free Extracellular RNAs and Proteins as Predictive Biomarkers for HER2 Therapies in Breast Cancer",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer, HER2 Positive Breast Cancer, HER2 Negative Breast Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 330,
    "primaryOutcomeMeasure": "Identification of Extra Cellular RNAs/proteins in sera from cancer patients",
    "eligibilityCriteria": "Inclusion Criteria:\n\n1. Patient with a newly diagnosed (including metastatic) HER2 positive breast cancer, who is to commence HER2 targeted treatment.\n\n   OR\n\n   - Patient with a newly diagnosed HER2 negative breast cancer, who is to commence any type of treatment.\n2. Patient must be female and aged 18 years or over.\n3. Patient must provide written informed consent.\n\nExclusion Criteria:\n\n1. Patients who do not fulfil the inclusion criteria mentioned above",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}